Glaucoma News

PYC Therapeutics advances eye disease drug trials update

PYC Therapeutics advances eye disease drug trials update

PYC Therapeutics Advances Blinding Eye Disease Drug Trials: A New Dawn for Patients For the hundreds of thousands of individuals worldwide living with inherited retinal diseases (IRDs), the world can slowly fade to darkness. These genetic conditions, which include retinitis pigmentosa and Stargardt disease, have long been considered untreatable, leading to progressive vision loss and, […]

PYC Therapeutics advances eye disease drug trials update Read More »

Lab-Grown Retina Reveals Gene Change in Rare Eye Condition

Lab-Grown Retina Reveals Gene Change in Rare Eye Condition

Lab-Grown Retina Reveals Genetic Cause of Rare Childhood Eye Disease For families navigating the difficult diagnosis of a rare childhood eye disease, the path forward is often shrouded in uncertainty. Many conditions lack clear genetic explanations, making prognosis and treatment planning a formidable challenge. Now, a groundbreaking study has illuminated one such shadowy corner of

Lab-Grown Retina Reveals Gene Change in Rare Eye Condition Read More »

Lab-Grown Retina Study Reveals Gene Clue in Eye Disease

Lab-Grown Retina Study Reveals Gene Clue in Eye Disease

Lab-Grown Retina Uncovers Gene Clue for Rare Childhood Eye Disease For families navigating the complexities of a rare genetic condition, answers can feel frustratingly out of reach. This is especially true for Leber congenital amaurosis (LCA), a group of inherited retinal diseases that cause severe vision loss from infancy. But now, a groundbreaking approach using

Lab-Grown Retina Study Reveals Gene Clue in Eye Disease Read More »

Senju Launches New Dry Eye Disease Drug in Japan

Senju Launches New Dry Eye Disease Drug in Japan

Senju Launches Innovative First-in-Class Dry Eye Drug in Japan For the millions in Japan suffering from the persistent discomfort of dry eye disease (DED), a new era of treatment has dawned. Senju Pharmaceutical Co., Ltd. has officially launched **TWYNA®**, a groundbreaking first-in-class drug offering a novel mechanism of action that moves beyond simple lubrication to

Senju Launches New Dry Eye Disease Drug in Japan Read More »

Scroll to Top